Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07334795

Intermountain Stewardship in Community Outpatient Settings-Resources & Engagement-Pediatrics

The goal of this implementation project is to detail the process of implementing the best practice of antibiotic stewardship in the pediatric population across the Intermountain Health medical system. The main questions it aims to answer are:

* How can a large healthcare system drive high adherence to antibiotic stewardship across a large and diverse number of sites? * How do determinants of implementation and needed strategies vary by context? * What is the utility of a higher-resource implementation effort (named "Boost) focusing on outlier sites?

Data will be collected on number of children reached, adherence changes over time, types of implementation strategies employed, and characteristics of sites, prescribers, and patients.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Respiratory Infection (for Example, Pneumonia, Bronchitis) Antibiotic Antibiotic Duration Antibiotic Prescribing for Acute Respiratory-tract Infections Bronchial Diseases Bronchitis Infections Lung Diseases Lung Diseases, Obstructive Pneumonia Respiratory Tract Diseases Respiratory Tract Infections

Age range

6 month–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Intermountain Medical Center

Murray, Utah, 84107, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 6 months through 17 years
  • ARTI diagnosis (acute otitis media (AOM), Group A Streptococcal (GAS) pharyngitis, acute sinusitis, and community-acquired pneumonia (CAP))

Exclusion criteria

  • Age <6months or >18 years
  • No ARTI diagnosis

Treatment and study plan

Implementation strategies including training & education, EMR tools, audit & feedback reports, and facilitation

Other

o facilitate improved adherence to guideline-based prescribing, we plan a variety of implementation strategies to be employed in tandem including training & education, EMR tools (e.g., Smart sets, express lanes, preference lists), audit and feedback reports and dashboards, and facilitation.

Primary outcomes

  1. Guideline-adherent Broad vs. Narrow Spectrum Antibiotic Prescribing

    Time frame: Baseline month adherence and post implementation (12 months). Maintenance period is 6 months post implementation.

    Rates of narrow-spectrum antibiotic (AB) prescriptions as a proportion of all antibiotics prescribed in aggregate and within each of these diagnoses: Acute otitis media, Group A streptococcal pharyngitis, Acute sinusitis, and Pneumonia.

  2. Guideline-adherent Duration of Antimicrobial Therapy

    Time frame: Baseline month adherence and post implementation (12 months). Maintenance period is 6 months post implementation.

    Rate of AB prescriptions with guideline-adherent number of days prescribed as proportion of all AB prescriptions in aggregate and for each of the target ARTI diagnoses.

Secondary outcomes

  1. Rate of Treatment Failure

    Time frame: Baseline month adherence and post implementation (12 months). Maintenance period is 6 months post implementation

    Clinical encounter for the same diagnosis between 2 and 14 days following the index encounter and receipt of an alternative antibiotic for the same respiratory diagnosis during the return visit.

  2. Adoption (Staff): Adherence to Protocols

    Time frame: Baseline month adherence and post implementation (12 months). Maintenance period is 6 months post implementation

    Number and proportion of prescribers who are "adherent" to guideline-based prescribing protocols for Broad vs. Narrow Spectrum AB Prescribing, and Duration.

  3. Adoption (Organization): Adherence to Protocols

    Time frame: Baseline month adherence and post implementation (12 months). Maintenance period is 6 months post implementation.

    Number and proportion of sites where 60% of prescribers are adherent.

Sponsors and collaborators

Lead sponsor

Intermountain Health Care, Inc.

Other

Registry information

Acronym: SCORE-Peds

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
Jan 12, 2026
Registry last updated
Mar 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.